Table 1.
Liver and spleen indices among different Schistosoma mansoni-infected mice groups, treated with praziquantel and dapagliflozin as mono- or combined therapy.
| Mice groups | Liver index a | Spleen index a |
|---|---|---|
| Infected non-treated (n = 6) | 7.05 ± 0.79 | 1.44 ± 0.19 |
| DMSO (n= 5) | 6.89 ± 0.29 | 1.34 ± 0.23 |
| PZQ (n = 6) | 5.81 ± 0.97(17.59) * | 0.81 ± 0.35(43.75) * |
| DAPA (n = 5) | 6.05 ± 0.23 (14.18) * | 1.04 ± 0.05 (27.78) * |
| DAPA + PZQ (n = 6) | 5.86 ± 0.13 (16.88) * | 0.83 ± 0.10 (42.36) * |
| P-value | P = 0.003 | P ≤ 0.001 |
a Analysis of variance (ANOVA) test. Data are expressed as means ± standard deviation
Values enclosed between parentheses represent the percentage of reduction, compared to infected non-treated group
DAPA: dapagliflozin; DMSO: dimethyl sulfoxide; PZQ: praziquantel
* Significant difference against infected non-treated, and DMSO-treated groups at P˂ 0.05